Literature DB >> 22565639

Interfacial interaction between transmembrane ocular mucins and adhesive polymers and dendrimers analyzed by surface plasmon resonance.

I Bravo-Osuna1, M Noiray, E Briand, A M Woodward, P Argüeso, I T Molina Martínez, R Herrero-Vanrell, G Ponchel.   

Abstract

PURPOSE: Development of the first in vitro method based on biosensor chip technology designed for probing the interfacial interaction phenomena between transmembrane ocular mucins and adhesive polymers and dendrimers intended for ophthalmic administration.
METHODS: The surface plasmon resonance (SPR) technique was used. A transmembrane ocular mucin surface was prepared on the chip surface and characterized by QCM-D (Quartz Crystal Microbalance with Dissipation) and XPS (X-ray photoelectron spectroscopy). The mucoadhesive molecules tested were: hyaluronic acid (HA), carboxymethyl cellulose (CMC), hydroxypropylmethyl cellulose (HPMC), chitosan (Ch) and polyamidoamine dendrimers (PAMAM).
RESULTS: While Ch originated interfacial interaction with ocular transmembrane mucins, for HA, CMC and HPMC, chain interdiffusion seemed to be mandatory for bioadherence at the concentrations used in ophthalmic clinical practise. Interestingly, PAMAM dendrimers developed permanent interfacial interactions with transmembrane ocular mucins whatever their surface chemical groups, showing a relevant importance of co-operative effect of these multivalent systems. Polymers developed interfacial interactions with ocular membrane-associated mucins in the following order: Ch(1 %) > G4PAMAM-NH(2)(2 %) = G4PAMAM-OH(2 %) > G3.5PAMAM-COOH(2 %)>> CMC(0.5 %) = HA(0.2 %) = HPMC(0.3 %).
CONCLUSIONS: The method proposed is useful to discern between the mucin-polymer chemical interactions at molecular scale. Results reinforce the usefulness of chitosan and dendrimers as polymers able to increase the retention time of drugs on the ocular surface and hence their bioavailability.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22565639      PMCID: PMC3867740          DOI: 10.1007/s11095-012-0761-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  35 in total

Review 1.  The use of mucoadhesive polymers in ocular drug delivery.

Authors:  Annick Ludwig
Journal:  Adv Drug Deliv Rev       Date:  2005-09-28       Impact factor: 15.470

2.  Quantitative analysis of mucins in mucosal secretions using indirect enzyme-linked immunosorbent assay.

Authors:  Pablo Argüeso; Ilene K Gipson
Journal:  Methods Mol Biol       Date:  2006

3.  Surface plasmon resonance study of g protein/receptor coupling in a lipid bilayer-free system.

Authors:  Konstantin E Komolov; Ivan I Senin; Pavel P Philippov; Karl-Wilhelm Koch
Journal:  Anal Chem       Date:  2006-02-15       Impact factor: 6.986

4.  Analyzing the functions of large glycoconjugates through the dissipative properties of their absorbed layers using the gel-forming mucin MUC5B as an example.

Authors:  Mehmet Kesimer; John K Sheehan
Journal:  Glycobiology       Date:  2008-03-13       Impact factor: 4.313

5.  Mucoadhesion of hydroxypropylmethacrylate nanoparticles to rat intestinal ileal segments in vitro.

Authors:  C Pimienta; V Lenaerts; C Cadieux; P Raymond; J Juhasz; M A Simard; C Jolicoeur
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

Review 6.  Chitosan-based nanostructures: a delivery platform for ocular therapeutics.

Authors:  Maria de la Fuente; Manuela Raviña; Patrizia Paolicelli; Alejandro Sanchez; Begoña Seijo; Maria Jose Alonso
Journal:  Adv Drug Deliv Rev       Date:  2009-12-01       Impact factor: 15.470

7.  QCM Operation in Liquids:  An Explanation of Measured Variations in Frequency and Q Factor with Liquid Conductivity.

Authors:  M Rodahl; F Höök; B Kasemo
Journal:  Anal Chem       Date:  1996-07-01       Impact factor: 6.986

8.  Surface structure of human mucin using X-ray photoelectron spectroscopy.

Authors:  B G Russell; W E Moddeman; J C Birkbeck; S E Wright; D S Millington; R D Stevens; K E Dombrowski
Journal:  Biospectroscopy       Date:  1998

Review 9.  Functions of ocular surface mucins in health and disease.

Authors:  Flavio Mantelli; Pablo Argüeso
Journal:  Curr Opin Allergy Clin Immunol       Date:  2008-10

10.  Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines.

Authors:  Ilene K Gipson; Sandra Spurr-Michaud; Pablo Argüeso; Ann Tisdale; Tat Fong Ng; Cindy Leigh Russo
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-06       Impact factor: 4.799

View more
  15 in total

1.  N-Glycosylation affects the stability and barrier function of the MUC16 mucin.

Authors:  Takazumi Taniguchi; Ashley M Woodward; Paula Magnelli; Nicole M McColgan; Sylvain Lehoux; Sarah Melissa P Jacobo; Jérôme Mauris; Pablo Argüeso
Journal:  J Biol Chem       Date:  2017-05-09       Impact factor: 5.157

Review 2.  Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases.

Authors:  I Bravo-Osuna; V Andrés-Guerrero; P Pastoriza Abal; I T Molina-Martínez; R Herrero-Vanrell
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

Review 3.  An Update on Novel Ocular Nanosystems with Possible Benefits in the Treatment of Corneal Neovascularization.

Authors:  Chenchen Zhang; Yuan Yin; Jing Zhao; Yanxia Li; Yuanping Wang; Zhaoying Zhang; Lingzhi Niu; Yajuan Zheng
Journal:  Int J Nanomedicine       Date:  2022-10-19

4.  Binding of transmembrane mucins to galectin-3 limits herpesvirus 1 infection of human corneal keratinocytes.

Authors:  A M Woodward; J Mauris; P Argüeso
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

Review 5.  The ocular surface epithelial barrier and other mechanisms of mucosal protection: from allergy to infectious diseases.

Authors:  Flavio Mantelli; Jerome Mauris; Pablo Argüeso
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-10

Review 6.  Human ocular mucins: The endowed guardians of sight.

Authors:  Pablo Argüeso
Journal:  Adv Drug Deliv Rev       Date:  2021-12-04       Impact factor: 15.470

7.  Multifunctional nanotherapeutics for treatment of ocular disease.

Authors:  Tian Xia
Journal:  Ann Eye Sci       Date:  2017-04-28

8.  Delivering amoxicillin at the infection site - a rational design through lipid nanoparticles.

Authors:  Daniela Lopes-de-Campos; Rita M Pinto; Sofia A Costa Lima; Tiago Santos; Bruno Sarmento; Cláudia Nunes; Salette Reis
Journal:  Int J Nanomedicine       Date:  2019-04-23

Review 9.  Nanotechnology approaches for ocular drug delivery.

Authors:  Qingguo Xu; Siva P Kambhampati; Rangaramanujam M Kannan
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jan-Mar

10.  Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.

Authors:  Mariana M Silva; Raquel Calado; Joana Marto; Ana Bettencourt; António J Almeida; Lídia M D Gonçalves
Journal:  Mar Drugs       Date:  2017-12-01       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.